Roivant Sciences Ltd (NASDAQ:ROIV) is set to release its Q4 2025 earnings on May 29, 2025. The consensus estimate for Q4 2025 ...

Q4 2024 Earnings Call Transcript May 29, 2025 Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.22 ...

Roivant Sciences Ltd (ROIV) showcases robust cash reserves and strategic share repurchases while navigating legal uncertainties and competitive pressures.

We recently published a list of While Wall Street Naps, These 10 Stocks Run Wild. In this article, we are going to take a ...

Analysts anticipate Roivant Sciences to report an earnings per share (EPS) of $-0.16. The announcement from Roivant Sciences is eagerly anticipated, with investors seeking news of surpassing estimates ...

Roivant Sciences (NASDAQ:ROIV) will release its quarterly earnings report on Thursday, 2025-05-29. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Roivant ...

Good day, and welcome to the Roivant Fourth Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and ...

Roivant Sciences Ltd. (($ROIV)) has held its Q4 earnings call. Read on for the main highlights of the call. Roivant Sciences Ltd. recently held ...

In this article, we are going to take a look at where Roivant Sciences Ltd. (NASDAQ:ROIV) stands against other best-performing stocks. Roivant Sciences ended a three-day losing streak on Thursday ...

Roivant Sciences Ltd. (ROIV) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.23 per share a year ago.

On Wednesday, H.C. Wainwright reaffirmed its Buy rating and $18.00 price target for Roivant Sciences (NASDAQ: ROIV), following a detailed discussion with the company’s CEO, Matthew Gline ...